Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammography | 15 | 2019 | 471 | 2.410 |
Why?
|
| Breast Neoplasms | 31 | 2023 | 3053 | 2.180 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 11 | 2024 | 471 | 1.400 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2023 | 3509 | 0.870 |
Why?
|
| Artificial Intelligence | 7 | 2025 | 358 | 0.780 |
Why?
|
| Image Interpretation, Computer-Assisted | 10 | 2025 | 693 | 0.670 |
Why?
|
| Radiographic Image Enhancement | 6 | 2019 | 465 | 0.650 |
Why?
|
| Diagnosis, Computer-Assisted | 6 | 2025 | 334 | 0.630 |
Why?
|
| ROC Curve | 15 | 2023 | 785 | 0.620 |
Why?
|
| Algorithms | 14 | 2025 | 1956 | 0.610 |
Why?
|
| Risk Assessment | 6 | 2019 | 2369 | 0.590 |
Why?
|
| Image Enhancement | 8 | 2018 | 562 | 0.450 |
Why?
|
| Genomics | 2 | 2019 | 806 | 0.440 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 1398 | 0.410 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2025 | 1271 | 0.410 |
Why?
|
| Glucuronosyltransferase | 1 | 2014 | 186 | 0.400 |
Why?
|
| Pattern Recognition, Automated | 7 | 2013 | 222 | 0.370 |
Why?
|
| Retrospective Studies | 13 | 2025 | 9703 | 0.330 |
Why?
|
| Breast | 6 | 2018 | 289 | 0.320 |
Why?
|
| Female | 35 | 2025 | 47893 | 0.310 |
Why?
|
| Diagnostic Imaging | 4 | 2025 | 456 | 0.300 |
Why?
|
| Genes, BRCA2 | 3 | 2014 | 161 | 0.260 |
Why?
|
| Middle Aged | 18 | 2025 | 27030 | 0.250 |
Why?
|
| Data Curation | 1 | 2025 | 4 | 0.250 |
Why?
|
| Health Information Interoperability | 1 | 2025 | 3 | 0.250 |
Why?
|
| Machine Learning | 4 | 2023 | 298 | 0.250 |
Why?
|
| Adnexal Diseases | 1 | 2025 | 18 | 0.240 |
Why?
|
| Adult | 17 | 2025 | 27532 | 0.240 |
Why?
|
| Humans | 38 | 2025 | 92337 | 0.240 |
Why?
|
| Aged | 15 | 2025 | 19943 | 0.230 |
Why?
|
| Thyroid Nodule | 1 | 2025 | 60 | 0.220 |
Why?
|
| Genes, BRCA1 | 3 | 2014 | 192 | 0.220 |
Why?
|
| Hydronephrosis | 1 | 2023 | 30 | 0.220 |
Why?
|
| Breast Density | 3 | 2019 | 35 | 0.210 |
Why?
|
| Phenotype | 5 | 2019 | 2498 | 0.210 |
Why?
|
| Radiologists | 1 | 2024 | 51 | 0.210 |
Why?
|
| Software | 5 | 2023 | 675 | 0.200 |
Why?
|
| Aged, 80 and over | 7 | 2019 | 6916 | 0.190 |
Why?
|
| Radiography, Thoracic | 1 | 2024 | 332 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2019 | 2394 | 0.180 |
Why?
|
| Tumor Burden | 2 | 2019 | 314 | 0.170 |
Why?
|
| BRCA2 Protein | 3 | 2008 | 165 | 0.170 |
Why?
|
| Pilot Projects | 4 | 2023 | 900 | 0.170 |
Why?
|
| Contrast Media | 7 | 2019 | 1076 | 0.170 |
Why?
|
| Parenchymal Tissue | 1 | 2019 | 6 | 0.160 |
Why?
|
| Databases, Factual | 2 | 2014 | 955 | 0.150 |
Why?
|
| Mutation | 5 | 2015 | 4204 | 0.150 |
Why?
|
| Area Under Curve | 4 | 2013 | 337 | 0.130 |
Why?
|
| Sensitivity and Specificity | 7 | 2024 | 2009 | 0.130 |
Why?
|
| Bayes Theorem | 3 | 2013 | 389 | 0.130 |
Why?
|
| Genetic Association Studies | 2 | 2015 | 294 | 0.120 |
Why?
|
| BRCA1 Protein | 2 | 2008 | 207 | 0.120 |
Why?
|
| Carcinoma, Lobular | 1 | 2015 | 81 | 0.120 |
Why?
|
| Mammary Glands, Human | 1 | 2014 | 24 | 0.110 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2015 | 160 | 0.110 |
Why?
|
| Fourier Analysis | 1 | 2014 | 128 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1477 | 0.110 |
Why?
|
| Subtraction Technique | 2 | 2011 | 130 | 0.100 |
Why?
|
| Multigene Family | 1 | 2014 | 203 | 0.100 |
Why?
|
| Age Factors | 2 | 2008 | 1905 | 0.100 |
Why?
|
| Risk Management | 1 | 2012 | 43 | 0.100 |
Why?
|
| Evaluation Studies as Topic | 1 | 2012 | 271 | 0.100 |
Why?
|
| Ultrasonography | 2 | 2025 | 708 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2012 | 219 | 0.100 |
Why?
|
| Age Distribution | 1 | 2012 | 206 | 0.100 |
Why?
|
| Gene Frequency | 1 | 2014 | 696 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2015 | 552 | 0.090 |
Why?
|
| Gene Expression | 1 | 2016 | 1312 | 0.090 |
Why?
|
| Reproducibility of Results | 7 | 2013 | 2794 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 1763 | 0.090 |
Why?
|
| Discriminant Analysis | 2 | 2010 | 66 | 0.090 |
Why?
|
| Genome, Human | 1 | 2015 | 799 | 0.090 |
Why?
|
| Alleles | 1 | 2014 | 1141 | 0.090 |
Why?
|
| Genotype | 1 | 2014 | 1863 | 0.080 |
Why?
|
| Incidence | 1 | 2012 | 1661 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 1576 | 0.070 |
Why?
|
| Fractals | 1 | 2007 | 42 | 0.070 |
Why?
|
| Observer Variation | 2 | 2024 | 612 | 0.060 |
Why?
|
| Young Adult | 2 | 2024 | 6624 | 0.060 |
Why?
|
| Radiology | 1 | 2008 | 205 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 2447 | 0.060 |
Why?
|
| Absorptiometry, Photon | 1 | 2004 | 106 | 0.050 |
Why?
|
| Osteoporosis | 1 | 2004 | 124 | 0.050 |
Why?
|
| Bone Density | 1 | 2004 | 226 | 0.050 |
Why?
|
| Reference Standards | 1 | 2023 | 144 | 0.050 |
Why?
|
| Risk | 1 | 2004 | 661 | 0.050 |
Why?
|
| Biopsy | 2 | 2017 | 1194 | 0.050 |
Why?
|
| Risk Factors | 2 | 2014 | 5704 | 0.050 |
Why?
|
| Chemistry, Physical | 1 | 2001 | 29 | 0.050 |
Why?
|
| Lung Diseases | 1 | 2024 | 282 | 0.050 |
Why?
|
| Benzoates | 1 | 2001 | 33 | 0.050 |
Why?
|
| Automation | 2 | 2014 | 112 | 0.040 |
Why?
|
| Pollen | 1 | 2001 | 84 | 0.040 |
Why?
|
| Fuzzy Logic | 2 | 2010 | 16 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2001 | 361 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2010 | 376 | 0.040 |
Why?
|
| Equipment Failure Analysis | 2 | 2010 | 88 | 0.030 |
Why?
|
| Water | 2 | 2014 | 292 | 0.030 |
Why?
|
| Lung | 1 | 2024 | 1337 | 0.030 |
Why?
|
| Echo-Planar Imaging | 1 | 2017 | 52 | 0.030 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2017 | 109 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 812 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 1181 | 0.030 |
Why?
|
| Prognosis | 2 | 2015 | 3872 | 0.030 |
Why?
|
| Models, Statistical | 2 | 2008 | 578 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 1592 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 469 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2014 | 80 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 569 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 2680 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 795 | 0.030 |
Why?
|
| Heterozygote | 1 | 2014 | 379 | 0.030 |
Why?
|
| Probability | 1 | 2014 | 357 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 1743 | 0.030 |
Why?
|
| Lipids | 1 | 2014 | 278 | 0.020 |
Why?
|
| Child | 1 | 2023 | 7334 | 0.020 |
Why?
|
| Male | 2 | 2025 | 43925 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 217 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1163 | 0.020 |
Why?
|
| Adolescent | 1 | 2024 | 9504 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 575 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 305 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 2035 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 359 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 255 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2011 | 390 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2010 | 74 | 0.020 |
Why?
|
| Equipment Design | 1 | 2010 | 418 | 0.020 |
Why?
|
| Liver | 1 | 2013 | 1228 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 4468 | 0.010 |
Why?
|
| Calcaneus | 1 | 2004 | 40 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 608 | 0.010 |
Why?
|
| Mass Screening | 1 | 2007 | 675 | 0.010 |
Why?
|
| Mineral Oil | 1 | 2001 | 1 | 0.010 |
Why?
|
| Papaver | 1 | 2001 | 2 | 0.010 |
Why?
|
| Deuterium Oxide | 1 | 2001 | 10 | 0.010 |
Why?
|
| Viscosity | 1 | 2001 | 49 | 0.010 |
Why?
|
| Plants, Medicinal | 1 | 2001 | 40 | 0.010 |
Why?
|
| Zea mays | 1 | 2001 | 27 | 0.010 |
Why?
|
| Microspheres | 1 | 2001 | 101 | 0.010 |
Why?
|
| Seeds | 1 | 2001 | 59 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2001 | 283 | 0.010 |
Why?
|
| Polymers | 1 | 2001 | 201 | 0.010 |
Why?
|